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Abstract
Cell adhesion molecules in Saccharomyces cerevisiae and Candida albicans contain amyloid-forming sequences that are
highly conserved. We have now used site-specific mutagenesis and specific peptide perturbants to explore amyloid-
dependent activity in the Candida albicans adhesin Als5p. A V326N substitution in the amyloid-forming region conserved
secondary structure and ligand binding, but abrogated formation of amyloid fibrils in soluble Als5p and reduced cell surface
thioflavin T fluorescence. When displayed on the cell surface, Als5p with this substitution prevented formation of adhesion
nanodomains and formation of large cellular aggregates and model biofilms. In addition, amyloid nanodomains were
regulated by exogenous peptides. An amyloid-forming homologous peptide rescued aggregation and biofilm activity of
Als5p
V326N cells, and V326N substitution peptide inhibited aggregation and biofilm activity in Als5p
WT cells. Therefore,
specific site mutation, inhibition by anti-amyloid peturbants, and sequence-specificity of pro-amyloid and anti-amyloid
peptides showed that amyloid formation is essential for nanodomain formation and activation.
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Introduction
Candida albicans is a human commensal fungus that is pathogenic
when its growth becomes uncontrolled, especially in imunocom-
promised individuals. Under such conditions these eukaryotes can
form biofilms that are resistant to a variety of environmental
assaults, including antimicrobials [1,2,3]. The formation of
biofilms is a developmental process with multiple steps including
cell adhesion, extracellular matrix production and the formation of
hyphae [4,5].
Cell wall proteins called adhesins are critical for biofilm
formation, and mediate adhesion of C. albicans to various substrates
and each other. Among many adhesins, members of the Als family
of glycoproteins are particularly active in cell aggregation,
adhesion to endothelia and epithelia, formation of biofilms and
pathogenesis in mouse models. There are eight ALS gene loci, with
high heterozygosity, so Als adhesin sequences and binding
specificities are diverse. However, all Als proteins have similar
modularity and domain structure (Figure 1A) [6,7]. Three
N-terminal Ig-like domains determine substrate specificity
[7,8,9]. A 103-residue Thr-rich T domain is highly conserved
among paralogs, and contains a 7-residue sequence that forms
amyloids under native–like conditions [10,11]. The central region
of the protein contains a variable number of tandem repeats (TR
domains) that are 36 amino acids in length, and these repeats bind
to each other and to substrates through the hydrophobic effect
[12,13]. A highly glycosylated, C-terminal, serine- threonine-rich
(Ser/Thr) stalk precedes a GPI anchor, which is processed to form
a covalent linkage to cell wall polysaccharide [14]. The
overlapping binding specificities and variable expression of Als
proteins make them difficult to study in C. albicans [6,7,9,15].
Nevertheless, expression in Saccharomyces cerevisiae has shown that
Als1p, Als3p and Als5p bind similarly to a variety of substrates and
are involved in endothelial cell adhesion, fungal aggregation, and
tissue invasion [7,16,17,18,19].
Als-mediated adhesion to substrate is followed 5–20 min later
by aggregation of Als-expressing yeast cells [20]. This aggregation
is accompanied by a cell surface conformational change in the Als
proteins to mediate stronger adhesive interactions [13,21]. This
activation is independent of cellular metabolism, because it occurs
in heat-killed cells [13].
The T domains of Als proteins contain amyloid-forming
sequences that are highly conserved [10]. Amyloids are insoluble
fibrillar protein aggregates whose cores consist of crystalline arrays
of identical sequences in many molecules of the amyloid protein
[22,23]. In the presence of amyloids, Congo red absorbance is red-
shifted and increased, and the fluorescence emission of thioflavin
T increases several fold [24,25,26]. At high concentrations, these
dyes can perturb amyloid structure [27,28,29]. Some amyloid-
forming bacterial adhesins can elicit cell-cell and cell-substrate
adhesion leading to the formation of biofilms [30,31,32]. Other
known roles for amyloid include amyloid-like stacking of residues
in b-helices in viral spike proteins [33], curli in gram negative
bacteria [30,32,34], sequestration of regulatory proteins in yeast
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17632Figure 1. Effect of V326N mutation on Als5p expression and aggregation in Saccharomyces cerevisiae. (A) Maps of Als5p
WT and
Als5p
V326N. The open reading frame is 1419 amino acid residues long, and the mutation is near the N-terminus of the 103-residue T domain.
(B) Immunofluorescence analysis shows expression of V5-tagged Als5p
WT and Als5p
V326N in S. cerevisiae. (C) Adherence and aggregation of yeast cells
(gray) to heat denatured BSA-coated beads (brown-gold) for S. cerevisiae without Als5p (EV) or expressing Als5p
WT or Als5p
V326N. Images shown were
visualized using bright field microscopy. The diameter of the beads is 2.8 mm.
doi:10.1371/journal.pone.0017632.g001
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template activity for melanin assembly [37].
Previously, we showed that the amyloid sequence in the T
region of Als proteins mediates amyloid formation, and that
amyloid binding dyes can inhibit aggregation in the S. cerevisiae
surface display model [8,10,11]. However, there is no direct data
for the roles of Als amyloid sequences per se in vivo. We have
therefore created a version of Als5p with its amyloid sequence
disrupted by a single site substitution, and assayed its effects in the
S. cerevisiae display model. We report the effects of this mutation on
aggregation and biofilm formation in a model system. In addition,
we have tested amyloid-forming and amyloid-inhibiting peptides
for their effect in vivo in C. albicans. Finally, we provide direct
evidence for the formation of amyloid adhesion nanodomains in
C. albicans, using single-molecule atomic force microscopy (AFM)
[38].
Results
Cells expressing a mutation in the amyloid sequence of
Als5p exhibit less efficient aggregation
S. cerevisiae cells expressing Als5p form large aggregates, similar
to those seen in C. albicans [8,39]. This cell aggregation can be
inhibited by amyloid binding dyes [8,11]. A V326N mutation in
the Als5p sequence reduces TANGO b-aggregation potential of
the amyloid region from 93% to 4% [10]. To test the hypothesis
that the amyloid forming sequence is critical for cell aggregation,
we incorporated the V326N mutation into full length wild type
Als5p, and expressed it in S. cerevisiae (Figure 1A). Immunofluo-
rescence confirmed that that both wild type Als5p (Als5p
WT) and
the substitution sequence (Als5p
V326N) were expressed on the yeast
cell surface, with non-amyloid Als5p
V326N expression slightly
greater than Als5p
WT (Figure 1B). In agreement with previous
results, cells expressing Als5p
WT bound to heat denatured BSA-
coated beads and formed large aggregates (Figure 1C) [8,11,39].
Cells expressing Als5p
V326N also bound to most of the beads, but
formed much smaller aggregates. S. cerevisiae with vector alone did
not bind to beads or form aggregates. Therefore, the V326N
substitution had a small effect on binding BSA as a ligand, but a
compromised the ability of Als5p to mediate formation of yeast
aggregates.
Increased thioflavin T fluorescence is a characteristic test for
amyloid formation [40]. Aggregated C. albicans or Als5p
WT
S.cerevisae cells stained brightly with 100 nM thioflavin T
(Figure 2O and 2P), a concentration that had no effect on cell
aggregation (Figure 2A–2D vs. 2I-2L). In contrast the small
aggregates of cells expressing Als5p
V326N showed little fluorescence
under these conditions (Figure 2N). Therefore, thioflavin T fluore-
scence was associated with robust aggregation of cells expre-
ssing amyloid-forming adhesins.
Figure 2. Thioflavin T fluorescence of S. cerevisiae and C. albicans. S. cerevisiae expressing no Als5p (EV), Als5p
V326N, Als5p
WT,o rC. albicans
were aggregated in the (A–H) absence or (I–P) presence of 100 nM thioflavin T. Aggregation state (upper panels) and thioflavin T fluorescence (lower
panels) were monitored. The diameter of the beads is 2.8 mm, and all images are at the same magnification.
doi:10.1371/journal.pone.0017632.g002
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red and thioflavin T inhibit aggregation of S. cerevisiae cells
expressing Als proteins [11,17]. If these dyes are acting through
perturbation of the amyloid, they should not affect the adherence
or residual aggregation of cells expressing Als5p
V326N.W e
determined dye concentrations inhibiting cell aggregation and
substrate binding for Congo red and thioflavin T (Figure 3). Both
Als5p
WT and C. albicans showed inhibition of aggregation in the
presence of 100nM Congo red (Figures 3A vs. 3B and 3F vs. 3G).
This concentration had no visual effect on the ability of the
Als5p
V326N to mediate formation of small aggregates (Figures 3K
vs. 3L). Furthermore, this concentration is at least a thousand-fold
lower than the concentrations that inhibit growth and fungal cell
wall biogenesis [41]. A higher concentration of Congo red
(300 mM) reduced the ability of both Als5p
WT and Als5p
V326N
cells to bind to the beads and form aggregates (Figures 3H and
3M). Negative control cells did not aggregate with or without
treatment (Figures 3P–3R).
Thioflavin T (5 mM and 450 mM) also decreased cell-cell
adhesion in C. albicans (Figure 3A vs. 3D and 3E) and S. cerevisiae
expressing Als5p
WT (Figure 3F vs. 3I and 3J). Thioflavin T had no
effect on the smaller aggregates of S. cerevisiae Als5p
V326N cells
(Figure 3N and 3O) or on empty vector cells (Figure 3S and 3T).
These data support the idea that most Als-mediated aggregation is
dependent on formation of amyloids.
V326N soluble protein is deficient in amyloid formation
and maintains native substrate binding activity
We expressed the V326N mutation in two soluble versions of
the Als5p protein: Als5p
1-431, including the Ig-like and Thr-rich
amyloid region; and Als5p
1-664, which also includes the tandem
repeat region [8,10,12]. The proteins containing the V326N
substitution were purified by published procedures and did not
form amyloid fibers visible by electron microscopy (data not
shown). When these soluble proteins were tested in modified
ELISA assays for in vitro binding to fibronectin and polystyrene, the
results were similar to those for the wild type Als5 protein within
experimental error for both the 431-residue and 664-residue
fragments. (Figure S1). Therefore, the in vitro binding properties of
the proteins were not significantly altered by the substitution. Far
UV Circular Dichroism spectra and secondary structure were also
similar to those from the corresponding proteins with wild type
sequences (Figure S2). These results demonstrated that the V326N
substitution did not significantly affect ligand binding properties or
secondary structure of Als5p.
An amyloid-forming peptide restores aggregation of
non-amyloid-forming cells
A tridecapeptide consisting of the sequence of Als5p
WT residues
322–334 (SNGIVIVATTRTV, amyloid sequence bolded) rapidly
forms insoluble amyloids [10]. We reasoned that its strong
amyloid-forming ability might increase amyloid formation in
non-amyloid Als5p
V326N by providing a stable amyloid template.
S. cerevisiae expressing either form of Als5p and C. albicans were
incubated without (Figure 4A–4H) or with this wild-type sequence
tridecapeptide (2 mg/ml) (Figure 4I–4P) during the bead assay.
This peptide greatly increased aggregate formation in S. cerevisiae
expressing Als5p
V326N (Figure 4B vs. 4J). The peptide had no
detectable effect on the aggregation of empty vector, or Als5p
WT-
expressing S. cerevisiae or on C. albicans strains (Figure 4A vs. 4I, 4C
vs. 4K and 4D vs. 4L). A scrambled-sequence peptide with the
same amino acid composition as the Als5p amyloid-forming
sequence (VITGVTNIRTSVA) did not induce aggregation,
indicating that the observed effect was specific to the wild type
sequence (Figure S3).
To determine if the peptide-induced adhesion was accompanied
by formation of amyloid-like interactions, cells were stained with
thioflavin T (Figures 4E–4H vs. 4M–4P). The small Als5p
V326N
aggregates lacked intense thioflavin T fluorescence (Figure 4F). In
contrast, aggregates formed from Als5p
V326N-expressing cells in the
presenceofpeptideexhibitedmoreintensefluorescence(Figure4N).
In the presence of peptide, there was also increased fluorescence of
Figure 3. Effect of Congo red and thioflavin T on aggregation. (A–E) C. albicans, (F–J) Als5p
WT in S. cerevisiae or (K–O) Als5p
V326N in
S. cerevisiae, and (P–T) empty vector (EV) cells were aggregated with beads coated with heat denatured BSA in the absence and in the presence of
100 nM or 300 mM Congo Red or 5 mM or 450 mM thioflavin T. Aggregates were observed by light microscopy. The diameter of the beads is 2.8 mm.
doi:10.1371/journal.pone.0017632.g003
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WT-expressing
S. cerevisiae (Figure 4G vs. 4O and 4H vs. 4P). Thus, exogenous
amyloid-forming homologous sequence peptide induced increased
aggregation in non-amyloid cells, and increased amyloid fluores-
cence in aggregating cells as well.
Non-amyloid V326N peptide blocks aggregation
Since the amyloid-forming peptide potentiated aggregation of
the Als5p
V326N-expressing strain, we hypothesized that the mutant
peptide would block cell aggregation. All strains were incubated
with the V326N peptide (SNGIN
326IVATTRTV; 200 mg/ml)
during the bead assay (Figure 4). This peptide strongly inhibited
aggregation, including Als5p
WT-expressing S. cerevisiae and
C. albicans (Figure 4C vs. 4S and 4D vs. 4T). The few remaining
aggregates looked similar to those observed with Als5p
V326N
(Figure 4B). This peptide did not have an effect on either empty
vector or Als5p
V326N strains (Figures 4A vs. 4Q and 4B vs. 4R). A
scrambled V326N peptide (VITGNTNIRTSVA) did not block
aggregation indicating that the inhibitory effect is specific to the
V326N sequence (Figure S3).
Figure 4. Effects of amyloid and non-amyloid peptides on cellular aggregation and thioflavin T fluorescence. S. cerevisiae expressing
no Als5p (EV), Als5p
V326N, Als5p
WT,o rC. albicans were aggregated in the (A–H) absence, or (I–P) presence of amyloid forming or (Q–X) amyloid-
disrupting peptides. The amyloid-forming peptide was SNGIVIVATTRTV, and the amyloid-disrupting peptide was SNGINIVATTRTV. Each vertical pair
shows brightfield and thioflavin T fluorescence images of the same field. The diameter of the beads is 2.8 mm, and all images are at the same
magnification.
doi:10.1371/journal.pone.0017632.g004
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in C. albicans and Als5p
WT-expressing S. cerevisiae, we tested
whether it prevented formation of amyloid-like interactions. In
these strains, thioflavin T fluorescence was strongly reduced in the
presence of V326N peptide (Figure 4G and 4H vs. 4W and 4X).
The peptide had no effect on the fluorescence of the empty vector
and Als5p
V326N aggregates (Figure 4U and 4V). These results
show that the V326N peptide blocked amyloid formation and
aggregation mediated by Als5p in S. cerevisiae, as well as
aggregation in C. albicans.
The amyloid sequence of Als5p is critical for cell-cell
association and cell–substrate adhesion to polystyrene
We also tested to determine whether amyloid formation was
important for a model biofilm. S. cerevisiae expressing Als5p
WT or
C. albicans adhered to the polystyrene surface of a 96-well plate in
Tris-EDTA buffer. The non-adherent cells and buffer were
removed, and the adhering cells incubated in medium overnight
[42]. Microscopy and quantitative crystal violet staining of the
wells revealed that Als5p
WT-expressing S. cerevisiae and C. albicans
strains bound to the surface in aggregates (Figure 5A). Thioflavin
T( 5mM) partially dispersed the C. albicans aggregates and fully
dispersed the Als5p
WT-mediated aggregates of S. cerevisiae. This
thioflavin T treatment reduced adherence of Als5p-expressing
S. cerevisiae by about 16%, and C. albicans adherence by 45%
(Figure 5B). A 90-fold higher concentration of dye reduced
adherence to the plastic by 79% and 90% respectively. Congo red
had similar effects: 100 nM disrupted aggregates and partially
inhibited adherence; 300 mM blocked almost all adhesion
(Figure S4).
In contrast to cells expressing Als5p
WT, Als5p
V326N cells bound
to the surface as dispersed cells, rather than as aggregates
(Figure 5A). The lower concentrations of the dyes did not affect
the residual adherence to the plastic surface, and the higher
concentrations partially blocked adherence. Taken together, these
results show that adherence to polystyrene is followed by
aggregation to form a biofilm, and is mediated by the amyloid-
forming region of Als5p in the S. cerevisiae model. The similar
behavior in C. albicans further supports the hypothesis that amyloid
sequences in Als or other adhesins are important in biofilm
formation.
Effects of an amyloid-forming peptide and an amyloid
inhibitory peptide on model biofilms
Since a mutation in the Als5p amyloid-forming sequence
disrupted adherence and aggregation on plastic, we hypothesized
that the V326N and amyloid-forming Als5p peptides would also
affect adhesion on polystyrene. The cells were incubated without
or with amyloid forming peptide SNGIV
326IVATTRTV or the
V326N non-amyloid peptide. Microscopy and quantification
revealed that the amyloid forming peptide rescued S. cerevisiae
cells expressing Als5p
V326N. In the presence of the amyloid-
inducing peptide, these cells formed large aggregates like C. albicans
and S. cerevisiae cells expressing wild type protein (Figure 6A).
Conversely, the V326N peptide effectively blocked adherence and
aggregation on plastic for each type of cell.
Quantification of adhesion to the polystyrene confirmed that
Als5p
WT-S. cerevisiae and C. albicans cells that were treated with
amyloid-forming peptide bound better than untreated cells
(Figure 6B). Additionally, Als5p
V326N cells that were treated with
the wild type peptide exhibited a nearly two-fold increase in
adherence relative to cells not incubated with peptide. These
results show that a peptide inhibitor of amyloid formation can
abrogate adherence to plastic and biofilm-like aggregation, and
conversely that an activator of amyloid formation facilitates
biofilm formation.
AFM resolves Als adhesion nanodomains in S. cerevisae
and C. albicans cells
Lastly, we used single-molecule AFM to probe the distribution
of Als proteins in living C. albicans cells, with the aim to determine
whether they are initially evenly distributed and clustered
following application of force, as are Als proteins on S. cerevisiae
[43](Figure 7). Yeast cells were trapped into porous polymer
membranes, and analyzed using topographic imaging and
spatially-resolved force spectroscopy. We first analyzed the
S. cerevisiae surface display model expressing V5-tagged Als5p
proteins using AFM tips bearing anti-V5 antibodies (Figure 7A–
7L). Consistent with earlier work in S. cerevisiae [43] the initial
distribution of Als5p
WT was random (Figure 7B). Pulling on single
adhesins with the AFM tip induced the formation of adhesion
domains of 100-500 nm size (Figure 7C). In addition, the force-
induced nanodomains propagated over the entire cell surface,
since remote areas showed similar nanodomains (Figure 7D).
Als5p
WT remodelling was independent of cellular metabolic
activity since heat-killed cells show the same behavior as live cells
(Figure 7E–7H). Remarkably, Als5p clustering properties were
almost completely abolished in the V326N mutant (Figure 7I–7L),
indicating that amyloid interactions play a key role in clustering.
Because amyloid regions also appear in C. albicans (Figures 2–6)
and are accompanied by development of strong adhesion and
surface birefringence [8,11,20], we tested to see if there was similar
force-induced formation of adhesin nanodomains in C. albicans
(Figure 7M–7P). In this case, living C. albicans yeast cells were
probed with AFM tips bearing Als5p
1-433 fragments (Supplemental
Figure S5A) since these bind to all Als adhesins [13,16,43,44]. As
expected, the initial force mapping showed a random pattern of
Als proteins (colored pixels), with a surface density being greater
than in the S. cerevisiae surface display model (Figure 7N vs. 7B).
The adhesive forces were typical for Als-Als interactions (Figure
S5B; [44]). Force-extension curves showed patterns similar to
those reported earlier for Als5p-Als5p interactions [44], except
that the number of unfolding Tandem Repeat domains varied
from 3–33, the range known for Als alleles (Supplemental Figure
S5C; [6]). Upon remapping of the same region (Figure 7, map1’)
or a remote region on the same cell (Figure 7, map 2), the adhesin
molecules were clustered, as in the S. cerevisiae model. These
observations lead us to conclude that nanodomains form and
propagate in response to force in C. albicans, just as they do in
Als5p
WT-expressing S. cerevisiae.
Adhesion nanodomains are also visualized by confocal micros-
copy of thioflavin T-stained cells. Therefore we tested the effects of
the peptides on nanodomain formation in C. albicans. As in the
Als5p S. cerevisiae surface display cells, the native sequence peptide
potentiated nanodomain formation and the V326N substitution
peptide inhibited nanodomains. The sequence specificity of
nanodomain potentiation and inhibition implies that Als proteins
are major components of surface amyloids in C. albicans.
Discussion
Amyloid-forming sequences are widespread in fungal adhesion
proteins that form cellular aggregates [11]. That being said, there
remains the question of whether amyloid formation per se is the
function of these sequences in situ on the cell surface. We and
others previously reported that anti-amyloid treatments disrupt Als
protein-mediated aggregation [8,10,11,17]. We have also demon-
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PLoS ONE | www.plosone.org 6 March 2011 | Volume 6 | Issue 3 | e17632Figure 5. Effects of thioflavin T on binding and aggregation on a polystyrene surface. C. albicans or S. cerevisiae expressing Als5p
WT,
Als5p
V326N, or empty vector (EV) strains were adhered to a polystyrene surface in the absence and presence of 5 mM or 450 mM thioflavin T for 1.5 h.
Adherent cells were grown overnight, washed, stained with 1% crystal violet and imaged. (A) The bottoms of wells were imaged. (B) Triplicate
biofilms were quantified with crystal violet. Mean and standard deviation are shown. Significance was determined by Student’s T-test with p values
relative to untreated strains (p#0.05(*), p#0.01(**), and p#0.001(***)).
doi:10.1371/journal.pone.0017632.g005
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PLoS ONE | www.plosone.org 7 March 2011 | Volume 6 | Issue 3 | e17632Figure 6. Effects of wild type and V326N peptides on polystyrene biofilms. (A) C. albicans or S. cerevisiae expressing Als5p
WT, Als5p
V326N,o r
no Als5p (EV) strains were adhered to a polystyrene surface in the absence and presence of the wild-type peptide (2 ug/ml) or V326N peptide (200 ug/
ml)for1.5 h.Adherentcellsweregrownovernight,stainedwith1%crystalvioletandimaged.(B)Crystalvioletquantificationofbinding.Peptide-treated
strains with p values relative to untreated strains were determined as significant by Student’s T-test (p#0.05(*), p#0.01(**), and p#0.001(***)).
doi:10.1371/journal.pone.0017632.g006
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PLoS ONE | www.plosone.org 8 March 2011 | Volume 6 | Issue 3 | e17632Figure 7. Force-induced adhesion nanodomains in single live cells. (A) AFM topographic image (scale bar: 2 mm), in buffer, showing wild-
type S. cerevisiae cells expressing V5-tagged Als5p
WT proteins. (B) Adhesion force map (1 mm 61 mm) recorded with an anti-V5 tip on a given target
area of the native cell that was never subjected to force (maps #1, recorded on the square shown in (A). Blue and red pixels correspond to forces
smaller and larger than 150 pN, respectively, thus to V5-tagged Als5p
WT recognition and unfolding. (C) Second adhesion force map (1 mm 61 mm)
recorded on the same target area (map #19). The heterogeneous distribution of coloured pixels, which represents the detection of single Als5p
WT
molecules documents the formation of nanoscale clusters (outlined in white). (D) Adhesion force map (1 mm 61 mm) recorded on a remote area
(map #2) localized several hundred nanometers away from the first map (see squares in A). (E–H) Same sequence of data as in A–D obtained on heat-
killed S. cerevisiae cells expressing Als5p
WT. (I–L) Same sequence of data as in A–D obtained on S. cerevisiae expressing ALS5p
V326N. (M) AFM
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surface nanodomains [43], but have not previously shown the
functional consequences of this mutation. Therefore we set out to
test directly the hypothesis that cell surface assembly of amyloids
causes nanodomain formation and activation of adhesion. These
new direct tests showed: first, that the V326N substitution in the
amyloid core region of the intact cell surface-localized protein
abrogated activation of adhesion; second, that the substitution did
not affect secondary structure of the protein or its affinity for
ligands; third, in agreement with the previous point, initial binding
of cells to substrate was not affected by the substitution (Figures. 1,
S1 and S2). We also took an independent and novel approach of
monitoring effects of sequence-specific pro- and anti-amyloid
peptides on nanodomain formation and adhesion activity. The
effects were supportive of the hypothesis: the anti-amyloid peptide
inhibited both nanodomain formation and adhesion activity, and
the pro-amyloid peptide activated, even in cells expressing the
V326N substituted protein. We also demonstrated for the first time
that there are force-induced nanodomains on the surface of
C. albicans and that the peptides perturb them. Finally, we showed
that the peptides act similarly in a model biofilm, as do anti-
amyloid dyes, a result also recently reported for Als3p by Nobbs
et al. [17]. Together, these approaches confirm the hypothesis,
showing that adhesion activity is increased by amyloid assembly
and nanodomain formation. The widespread occurrence and the
conservation of amyloid sequences in fungal adhesins are
consistent with amyloid-mediated nanodomain formation being
a general mechanism for activation of robust cell-cell aggregation.
We have tested this hypothesis by a detailed determination of
phenotype for single site substitution V326N in the 1419 amino-
acid Als5p sequence. This mutation is in the seven residue
amyloid-forming sequence I
325VIVATT
331 in the highly con-
served T domain of Als5p. The mutation reduces the TANGO
b-aggregation potential, which is related to amyloid-forming
ability, from .95% to 4% [45]. A peptide with this sequence
change did not form amyloids in vitro [10]. Although 431-, and
664-residue fragments of Als5p
WT form amyloid fibers [10,11], the
corresponding soluble versions of Als5p
V326N did not (data not
shown).
Therefore, the V326N mutation abrogated amyloid formation in
vitro and also altered the activity of cell-bound Als5p. The mutation
did not significantly affect cell wall localization of the protein
(Figure 1), secondary structure (Figure S2), or binding of soluble
Als5p to polystyrene or fibronectin (Figure S1). These results imply
that the mutated protein folded to its native structure and retained
its binding activity. Furthermore Als5p
V326N cell surface expression
was consistent with proper folding and processing. Nevertheless,
cells expressing Als5p
V326N bound to polystyrene or to heat
denatured BSA-coated beads somewhat less efficiently than cells
expressing the wild type protein (Figures 1, 5, and 6). However,
there was a severe inhibition of cellular aggregation ability for cells
expressing Als5p
V326N. Thus the cellular consequences were great,
despite the observation that the mutation did not affect in vitro
activities of the soluble proteins. These consequences can be most
easily explained as a failure of the mutated protein to form
functional amyloid regions required for cell surface activation
through adhesion nanodomain formation.
If the loss of amyloid formation is the key defect in Als5p
V326N,
then chemical inhibition of amyloid formation should show similar
effects, and the residual activity of the Als5p
V326N protein should
be resistant to the inhibitors. In fact these results were observed in
cellular assays of binding to bead-bound ligand (Figure 3), and in
the model biofilm study (Figures 5 and 6), the V326N mutant
phenotype was mimicked by low concentrations of amyloid-
perturbing dyes Congo red and thioflavin T. In keeping with this
interpretation, the residual activity of Als5p
V326N was not inhibited
by these dye concentrations, a result consistent with the remaining
activity being amyloid independent.
Thioflavin T at sub-inhibitory concentrations is standardly used
to monitor formation of amyloids in vitro [46,47], and thioflavin T
was highly useful to monitor the cell surface amyloid levels in
intact cells (Figures 3, 4, and 7). Unlike wild type cells, Als5p
V326N
cells showed minimal thioflavin T fluorescence, consistent with the
idea that the mutation compromised amyloid formation. For cells
expressing wild type Als5p, the fluorescence increased on
aggregation, implying that cell-cell contact resulted in increased
amyloid formation at the cell surface, both in the S. cerevisiae
display model and in C. albicans itself, results consistent with an
increase in cell surface birefringence [8,11]. We could also use the
technique to monitor peptide-induced modulation of cell surface
amyloid levels (Figures 3, 4, and 7).
The finding that peptides modulated both aggregation of cells
and cell surface amyloid levels in parallel was also consistent with
amyloid dependence of aggregation. Amyloids are highly sequence
specific, and form stacked b-sheets of identical sequences in many
molecules of the same protein [22,23]. Therefore, amyloid
formation is highly sensitive to addition of amyloid-forming or
amyloid-interfering peptides with sequences identical to or slightly
changed from the amyloid-forming region of the protein [48,49].
An amyloid-forming peptide rescued the S. cerevisiae cells expressing
Als5p
V326N, as well as increasing surface amyloid levels in cells
expressing Als5p
WT and in C. albicans (Figure 4). We propose that
the wild type sequence peptide reinforces amyloids with homolo-
gous sequence, and is able to form a ‘‘seed’’ that forces amyloid–like
interactions in Als5p
V326N. The converse experiment was also
informative: excess V326N peptide inhibited amyloid formation
and aggregation in cells expressing wild type adhesins. These effects
were sequence-specific, since sequence-scrambled peptides of the
same composition had no effects on aggregation or biofilm
formation (Figure S3). Therefore, the peptide studies confirmed a
specific role for amyloid formation in cellular aggregation.
That the V326N peptide inhibited aggregation and nanodo-
main formation in C. albicans also implies that Als1p or Als5p is the
major adhesin being assayed. Als1p, Als3p, and Als5p have
identical amyloid sequences, and Als1p is the major adhesin
expressed on C. albicans in the yeast form [6,50]. Therefore, the
peptides would likely affect aggregation caused by Als1p as well as
that caused by Als5p or Als3p.
topographic image of a C. albicans cell (scale bar: 2 mm). (N) Adhesion force map (1 mm61 mm) recorded with an Als5p
1-431-derivatized tip [44] on a
given target area of the native cell (map #1, recorded on the square in M; red pixels correspond to unfolding forces that are in the 0-300 pN range).
(O) Second adhesion force map (1 mm61 mm) recorded on the same target area (maps #19). (P) Adhesion force map (1 mm61 mm) recorded on a
remote area (map #2) localized several hundred nanometers away from the first map (see squares in M). (Q) Confocal imaging of punctate
fluorescent nanodomains (white arrows) on aggregated C. albicans treated with Als5p or Als5p
V326N peptide and stained with 100 nM thioflavin-T.
(R) Cartoon model of force-induced amyloid-dependent clustering of Als5p. Cell walls are shown as heavy greent lines. Als5p adhesion molecules
have green Ig-like binding domains, a red amyloid sequence, and a black line representing the TR and stalk domains. Application of pulling force in
the AFM or mixing in the aggregation assays causes formation of amyloid-like arrays on the cell surface. The formation of these arrays is blocked in
the presence of Congo red, high concentrations of thioflavin T, or by V326N peptide or mutation.
doi:10.1371/journal.pone.0017632.g007
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causing robust aggregation of cells expressing amyloid-forming
adhesins. Recent AFM studies show that the amyloid-forming
sequence in Als5p mediates force-induced clustering of the
adhesins on the cell surface [43]. Such clustering increases the
strength of adherence because it increases the chance that ligands
remain bound for long times: random dissociation of a ligand is
followed by immediate rebinding to a nearby adhesin. The
clustering lowers the macroscopic dissociation constant KD [51].
This effect is known from immunology as antibody avidity, the
increase in binding constant of intact antibody with multiple
binding sites relative to the dissociation constant of a single
monomeric FAb’. The clustering is absent in cells expressing
Als5p
V326N, a result consistent with amyloid formation being
important for adhesin clustering (Figure 7). Like increased
aggregation and amyloid formation, clustering is independent of
cellular metabolism and protein synthesis [8,39,43,52]. The Als
adhesins cluster even though they are anchored to the cell wall
polysaccharide [14,53]. This clustering is facilitated by the length
of the extended molecules, the longest of which can extend to
almost 500 nm, giving a radius of gyration of almost 1 mm across
the cell surface (Figure 7; Figure S5; [43]).
Thus, we find that amyloid-dependent clustering of Als5p to
form adhesion nanodomains would account for increased avidity
and robust aggregation (Figure 7Q). Amyloid formation at the cell
surface is accompanied by conformational shifts in pre-existing cell
surface proteins, and is co-temporal with development of robust
aggregation. Three different modulators of amyloid forming ability
prevented formation of thioflavin fluorescent amyloid nanodo-
mains and abrogated strong aggregation: namely mutation,
chemical perturbants, and an amyloid-disrupting peptide. Fur-
thermore, adhesion was enhanced after exogenous application of
an amyloid-forming Als5p homologous sequence peptide. The
enhancement was accompanied by increased amyloid fluores-
cence, and peptides with scrambled sequences had no effect. Thus
all of our results are consistent with amyloid formation itself being
an essential part of cellular aggregation. We cannot think of other
mechanisms consistent with the data.
Formation of amyloid-dependent adhesion nanodomains has
broad implications as a mechanism for yeast cell-cell adhesion in
general, as well as in mats and biofilms [15,42]. Amyloid
sequences are present in most yeast adhesins [11]. Furthermore,
for C. albicans Als proteins, and S. cerevisiae Flo1p and Muc1p/
Flo11p, adhesins, activity is inhibited by amyloid-perturbing dyes.
These results, together with our discovery of the effects of specific
sequence peptides promise new approaches to understanding and
manipulation of cell-cell interactions.
Materials and Methods
Strains and media
C. albicans strain Day 286 was a gift from J. Rauceo (John Jay
College, CUNY) and was grown in YPED with 80 mg/L uridine
at 30uC. S. cerevisiae strain W303-1B (Rodney Rothstein, Columbia
U.) was grown in CSM with galactose at 24uC. Cells harboring
empty vector (pJL1-EV), or expressing Als5p
WT or Als5p
V326N
were grown in CSM with galactose lacking Trp.
Generation of V5-tagged Als5p
WT and Als5p
V326N
V5-tagged Als5p
WT was generated by restriction digestion of
pGK114 with BamHI and XhoI which released the Als5p sequence
from the vector backbone [39]. This backbone was then ligated to:
an oligonucleotide, which contains sequences for the invertase
secretion signal, V5 epitope tag, flanked by a 59-BamHI and 39-
NotI restriction sites [54]. The coding region of Als5p between a 59
NotI site and a 39XhoI site was generated by PCR and was ligated
to the modified vector to make pJL1. The resulting construct was
verified by sequencing (GeneWiz, South Plainfield, NJ).
Als5p
V326N was generated by digestion of pGK114 with SphI
and AleI to generate a 363bp fragment at nucleotide position 1242
to 1605, containing the target sequence to be mutated. This
fragment was subcloned into pGEM-T vector and mutagenized
using Quickchange (Agilent Technologies, Santa Clara, CA) with
mutagenic primer 59-GAA TAG TGA TGC CGG ATC TAA
CGG TAT TAA CAT TGT TGC TAC AAC TAG AAC AGT
TAC AGA CAG-39. The correct mutation was verified by sequen-
cing. The mutated fragment was released from the vector with the
same enzymes used in its generation, and placed into the
corresponding position of pJL1. The resulting product, pJL1
V326N
was verified by sequencing to determine the presence of the full-
length Als5p
V326N.
pJL-EV was produced by restriction digestion of pJL1 with
BamHI and XhoI and ligating in the multiple cloning site from
p414 (ATCC, Manassas, VA). The pJL plasmids were transformed
into S. cerevisiae strain W303-1B.
Cell-bead assay
Cell aggregation was observed using a previously described
method with minor modifications [8]. Briefly, M-280 tosyl-
activated magnetic Dynabeads (Invitrogen, Carlsbad, CA) were
coated overnight at 37uC with 1 mg/ml heat-denatured BSA
according to the manufacturer’s protocol. Cells were washed and
resuspended in 10 mM Tris-HCl, 1 mM EDTA buffer, pH 7.0
(TE). Beads, 1610
6, were added to 1610
8 cells in 136100 mm
glass test tubes and the suspension was shaken at 200 rpm at 24uC
30-45 minutes. Adherent cells were separated and washed over a
magnet, resuspended in TE buffer and observed by microscopy.
Thioflavin T fluorescence was excited at 425 nm and monitored at
510 nm.
Polystyrene cell adhesion assay
Adhesion to polystyrene was assayed using a protocol previously
described [42] with the following modifications. Cells were
resuspended in TE alone or with dyes at 1610
7 cells/ml. Cell
suspension, 100 ml/well, was added to a polystyrene non-tissue
culture plate with 96 wells. Each sample was done in triplicate.
The cells adhered to the surface for 1.5 hours at room tempe-
rature. The polystyrene surface was washed with TE, sterile liquid
media was added and the adherent cells were incubated overnight
at 30uC. The next day the non-adherent cells were washed away
with TE. Adherent cells were stained with crystal violet and
observed by microscopy and imaged. Adhesion was quantified by
solubilization of the crystal violet in 10% SDS for 1.5 hours and
measuring the absorbance at 570 nm.
Atomic force microscopy
AFM measurements were performed at room temperature
(20uC) in buffered solutions (sodium acetate; pH 4.75), using a
Nanoscope IV Multimode AFM (Veeco Metrology Group, Santa
Barbara, CA) and oxide sharpened microfabricated Si3N4
cantilevers (Microlevers, Veeco Metrology Group). Cells were
immobilized by mechanical trapping into porous polycarbonate
membranes (Millipore), with a pore size similar to the cell size.
After filtering a concentrated cell suspension, the filter was gently
rinsed with buffer, carefully cut (1 cm 61 cm), attached to a steel
sample puck (Veeco Metrology Group) and the mounted sample
was transferred into the AFM liquid cell while avoiding dewetting.
The spring constants of the cantilevers were measured using the
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yielding values ranging from 0.008 to 0.021 N/m. All force
measurements were recorded with a loading rate of 10,000 pN/s.
AFM tips were functionalized with anti-V5 antibodies or
Als5p
1-431 protein as described earlier [43,44].
Supporting Information
Figure S1 ELISA assays of binding of Als5p
V326N substi-
tution proteins. The upper graph shows binding of increasing
concentrations of proteins to different concentrations of fibronec-
tin. The lower graph denotes binding of the proteins to
polystyrene. The constructs shown are Ig-T-TR, wildtype (N)
and V326N (.), and Ig-T wildtype (#) and V326N (D). The
protein concentration is 2.360.7mM for the fibronectin binding.
The assays were carried out as previously described [11].
(TIF)
Figure S2 Far UV Circular Dichroism spectra of
Als5p
1-664 protein. Wildtype protein is represented by the
solid line and the V326N substation by the dashed line at 20uC.
(TIF)
Figure S3 Effects of scrambled V326N (VITGVT-
NIRTSVA) and wild type peptide (VITGNTNIRTSVA)
on cellular aggregation. S. cerevisiae expressing no Als5p (EV),
Als5p
V326N, Als5p
WT,o rC. albicans were aggregated in the absence
and presence of 2mg/ml scrambled wild type (S-wild type) or 200
mg/ml scrambled peptide (S-V326N). The diameter of the beads is
2.8 mm, and all images are at the same magnification.
(TIF)
Figure S4 Amyloid binding dye Congo red reduces
binding and aggregation on polystyrene biofilms.
C. albicans or S. cerevisiae expressing Als5p
WT, Als5p
V326N,o rn o
Als5p (EV) adhered to a polystyrene surface in the absence and
presence of 100 nM or 300 mM Congo red for 1.5 h. Adherent
cells were grown overnight, stained with 1% crystal violet and
imaged.
(TIF)
Figure S5 Detection and unfolding of single Als proteins
in C. albicans. (A) Principle of the single-molecule detection
experiment. C. albicans cells are probed, in buffer, using AFM tips
derivatized with Als5p
1-431. (B) Force extension curves obtained by
stretching ALS proteins showed periodic features reflecting the
sequential unfolding of the TR domains. (C) Plot of the rupture
distances as a function of the number of unfolded TR.
(TIF)
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